{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:39:59Z","timestamp":1790138399924,"version":"4.0.1"},"reference-count":52,"publisher":"The Endocrine Society","issue":"6","funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Pathogenic variants in KCNJ5, encoding the GIRK4 (Kir3.4) potassium channel, have been implicated in the pathogenesis of familial hyperaldosteronism type-III (FH-III) and sporadic primary aldosteronism (PA). In addition to aldosterone, glucocorticoids are often found elevated in PA in association with KCNJ5 pathogenic variants, albeit at subclinical levels. However, to date no GIRK4 defects have been linked to Cushing syndrome (CS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patient<\/jats:title>\n                  <jats:p>We present the case of a 10-year-old child who presented with CS at an early age due to bilateral adrenocortical hyperplasia (BAH). The patient was placed on low-dose ketoconazole (KZL), which controlled hypercortisolemia and CS-related signs. Discontinuation of KZL for even 6 weeks led to recurrent CS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Screening for known genes causing cortisol-producing BAHs (PRKAR1A, PRKACA, PRKACB, PDE11A, PDE8B, ARMC5) failed to identify any gene defects. Whole-exome sequencing showed a novel KCNJ5 pathogenic variant (c.506T&amp;gt;C, p.L169S) inherited from her father. In vitro studies showed that the p.L169S variant affects conductance of the Kir3.4 channel without affecting its expression or membrane localization. Although there were no effects on steroidogenesis in vitro, there were modest changes in protein kinase A activity. In silico analysis of the mutant channel proposed mechanisms for the altered conductance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>We present a pediatric patient with CS due to BAH and a germline defect in KCNJ5. Molecular investigations of this KCNJ5 variant failed to show a definite cause of her CS. However, this KCNJ5 variant differed in its function from KCNJ5 defects leading to PA. We speculate that GIRK4 (Kir3.4) may play a role in early human adrenocortical development and zonation and participate in the pathogenesis of pediatric BAH.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab118","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T18:08:40Z","timestamp":1614276520000},"page":"1606-1616","source":"Crossref","is-referenced-by-count":7,"title":["Cushing Syndrome in a Pediatric Patient With a KCNJ5 Variant and Successful Treatment With Low-dose Ketoconazole"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2882-4584","authenticated-orcid":false,"given":"Christina","family":"Tatsi","sequence":"first","affiliation":[{"name":"Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"},{"name":"Internal medicine and Pediatric Endocrinology Inter-institute Training Programs, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea G","family":"Maria","sequence":"additional","affiliation":[{"name":"Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Malloy","sequence":"additional","affiliation":[{"name":"Section on Molecular Neurophysiology and Biophysics, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Lin","sequence":"additional","affiliation":[{"name":"Section on Molecular Neurophysiology and Biophysics, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edra","family":"London","sequence":"additional","affiliation":[{"name":"Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Settas","sequence":"additional","affiliation":[{"name":"Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsi","family":"Flippo","sequence":"additional","affiliation":[{"name":"Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"},{"name":"Internal medicine and Pediatric Endocrinology Inter-institute Training Programs, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Keil","sequence":"additional","affiliation":[{"name":"Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"},{"name":"Internal medicine and Pediatric Endocrinology Inter-institute Training Programs, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-6205","authenticated-orcid":false,"given":"Fady","family":"Hannah-Shmouni","sequence":"additional","affiliation":[{"name":"Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"},{"name":"Internal medicine and Pediatric Endocrinology Inter-institute Training Programs, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dax A","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Section on Molecular Neurophysiology and Biophysics, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4058-5520","authenticated-orcid":false,"given":"Constantine A","family":"Stratakis","sequence":"additional","affiliation":[{"name":"Section on Endocrinology & Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"},{"name":"Internal medicine and Pediatric Endocrinology Inter-institute Training Programs, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD 20892,USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"issue":"1","key":"2021122205025956500_B1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.21037\/gs.2019.10.22","article-title":"Primary aldosteronism diagnostics: KCNJ5 mutations and hybrid steroid synthesis in aldosterone-producing adenomas","volume":"9","author":"Rege","year":"2020","journal-title":"Gland Surg"},{"issue":"3","key":"2021122205025956500_B2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/ERC-12-0022","article-title":"KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn\u2019s syndrome","volume":"19","author":"Xekouki","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"2021122205025956500_B3","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"issue":"1","key":"2021122205025956500_B4","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1210\/jc.2014-3636","article-title":"A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue","volume":"100","author":"Monticone","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122205025956500_B5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mce.2016.07.031","article-title":"Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism","volume":"441","author":"Tamura","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"2021122205025956500_B6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ajh\/hpz172","article-title":"Mosaicism for KCNJ5 causing early-onset primary aldosteronism due to bilateral adrenocortical hyperplasia","volume":"33","author":"Maria","year":"2020","journal-title":"Am J Hypertens"},{"issue":"4","key":"2021122205025956500_B7","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021122205025956500_B8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EJE-14-1154","article-title":"Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations","volume":"172","author":"Lodish","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2021122205025956500_B9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.humpath.2014.09.005","article-title":"Germline PRKACA amplification leads to Cushing syndrome caused by 3 adrenocortical pathologic phenotypes","volume":"46","author":"Carney","year":"2015","journal-title":"Hum Pathol"},{"issue":"11","key":"2021122205025956500_B10","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"2021122205025956500_B11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1507\/endocrj.EJ14-0282","article-title":"Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication]","volume":"61","author":"Nakajima","year":"2014","journal-title":"Endocr J"},{"issue":"6","key":"2021122205025956500_B12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-14-1113","article-title":"PRKACA mutations in cortisol-producing adenomas and adrenal hyperplasia: a single-center study of 60 cases","volume":"172","author":"Thiel","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2021122205025956500_B13","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-16-0262","article-title":"Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations","volume":"175","author":"Nanba","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2021122205025956500_B14","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2013-3628","article-title":"Ketoconazole in Cushing\u2019s disease: is it worth a try?","volume":"99","author":"Castinetti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021122205025956500_B15","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1542\/peds.2006-2402","article-title":"Diagnostic tests for children who are referred for the investigation of Cushing syndrome","volume":"120","author":"Batista","year":"2007","journal-title":"Pediatrics"},{"issue":"2","key":"2021122205025956500_B16","first-page":"100","article-title":"Pediatric Cushing syndrome; an overview","volume":"17","author":"Tatsi","year":"2019","journal-title":"Pediatr Endocrinol Rev"},{"issue":"8","key":"2021122205025956500_B17","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1210\/jc.2017-00161","article-title":"Somatic USP8 gene mutations are a common cause of pediatric Cushing disease","volume":"102","author":"Faucz","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2021122205025956500_B18","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1210\/jc.2003-032247","article-title":"Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?","volume":"89","author":"Gunther","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2021122205025956500_B19","doi-asserted-by":"crossref","first-page":"E1532","DOI":"10.1210\/jc.2012-1334","article-title":"A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension","volume":"97","author":"Charmandari","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2021122205025956500_B20","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/cen.13132","article-title":"Functional characterization of two novel germline mutations of the KCNJ5 gene in hypertensive patients without primary aldosteronism but with ACTH-dependent aldosterone hypersecretion","volume":"85","author":"Sertedaki","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2021122205025956500_B21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods"},{"issue":"10","key":"2021122205025956500_B22","doi-asserted-by":"crossref","first-page":"e46688","DOI":"10.1371\/journal.pone.0046688","article-title":"Predicting the functional effect of amino acid substitutions and indels","volume":"7","author":"Choi","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"2021122205025956500_B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nprot.2015.123","article-title":"SIFT missense predictions for genomes","volume":"11","author":"Vaser","year":"2016","journal-title":"Nat Protoc"},{"key":"2021122205025956500_B24","year":"2001"},{"issue":"3","key":"2021122205025956500_B25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1432-1033.1996.00486.x","article-title":"Overexpression of RII beta regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII beta","volume":"235","author":"Nesterova","year":"1996","journal-title":"Eur J Biochem"},{"issue":"3","key":"2021122205025956500_B26","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/a-1107-2972","article-title":"A Gene-based classification of primary adrenocortical hyperplasias","volume":"52","author":"Hannah-Shmouni","year":"2020","journal-title":"Horm Metab Res"},{"issue":"8","key":"2021122205025956500_B27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1055\/a-1061-7349","article-title":"Update of genetic and molecular causes of adrenocortical hyperplasias causing Cushing syndrome","volume":"52","author":"Berthon","year":"2020","journal-title":"Horm Metab Res"},{"key":"2021122205025956500_B28","author":"Tatsi","year":"2020"},{"issue":"1","key":"2021122205025956500_B29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mce.2011.10.006","article-title":"The cAMP pathway and the control of adrenocortical development and growth","volume":"351","author":"de Joussineau","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"2021122205025956500_B30","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1210\/me.2014-1060","article-title":"Wnt signaling inhibits adrenal steroidogenesis by cell-autonomous and non-cell-autonomous mechanisms","volume":"28","author":"Walczak","year":"2014","journal-title":"Mol Endocrinol"},{"key":"2021122205025956500_B31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.mce.2014.12.014","article-title":"Adrenal cortex tissue homeostasis and zonation: a WNT perspective","volume":"408","author":"Drelon","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"2021122205025956500_B32","doi-asserted-by":"crossref","first-page":"12751","DOI":"10.1038\/ncomms12751","article-title":"PKA inhibits WNT signalling in adrenal cortex zonation and prevents malignant tumour development","volume":"7","author":"Drelon","year":"2016","journal-title":"Nat Commun"},{"key":"2021122205025956500_B33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2016.12.005","article-title":"Cell signaling pathways in the adrenal cortex: Links to stem\/progenitor biology and neoplasia","volume":"445","author":"Penny","year":"2017","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2021122205025956500_B34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.devcel.2013.07.016","article-title":"Adrenocortical zonation results from lineage conversion of differentiated zona glomerulosa cells","volume":"26","author":"Freedman","year":"2013","journal-title":"Dev Cell"},{"issue":"2","key":"2021122205025956500_B35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98394","article-title":"PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal","volume":"3","author":"Dumontet","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"2021122205025956500_B36","doi-asserted-by":"crossref","first-page":"e1000980","DOI":"10.1371\/journal.pgen.1000980","article-title":"Cushing\u2019s syndrome and fetal features resurgence in adrenal cortex-specific Prkar1a knockout mice","volume":"6","author":"Sahut-Barnola","year":"2010","journal-title":"PLoS Genet"},{"issue":"1","key":"2021122205025956500_B37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0896-6273(00)80438-9","article-title":"Abnormal heart rate regulation in GIRK4 knockout mice","volume":"20","author":"Wickman","year":"1998","journal-title":"Neuron"},{"issue":"23","key":"2021122205025956500_B38","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.1073\/pnas.0803261105","article-title":"Predisposition to late-onset obesity in GIRK4 knockout mice","volume":"105","author":"Perry","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2021122205025956500_B39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1042\/CS20171285","article-title":"Targeted disruption of the Kcnj5 gene in the female mouse lowers aldosterone levels","volume":"132","author":"Hardege","year":"2018","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"2021122205025956500_B40","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/s41467-020-15408-4","article-title":"Angiotensin II induces coordinated calcium bursts in aldosterone-producing adrenal rosettes","volume":"11","author":"Guagliardo","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"2021122205025956500_B41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI127429","article-title":"Chemogenetic activation of adrenocortical Gq signaling causes hyperaldosteronism and disrupts functional zonation","volume":"130","author":"Taylor","year":"2020","journal-title":"J Clin Invest"},{"issue":"11","key":"2021122205025956500_B42","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1210\/jc.2016-1504","article-title":"A novel phenotype of familial hyperaldosteronism type III: concurrence of aldosteronism and Cushing\u2019s syndrome","volume":"101","author":"Tong","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122205025956500_B43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fmed.2018.00054","article-title":"The many faces of primary aldosteronism and Cushing syndrome: a reflection of adrenocortical tumor heterogeneity","volume":"5","author":"Mete","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"2021122205025956500_B44","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz235","article-title":"Histological characterization of aldosterone-producing adrenocortical adenomas with different somatic mutations","volume":"105","author":"Ono","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2021122205025956500_B45","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/jc.2018-00738","article-title":"Aldosterone suppression by dexamethasone in patients with KCNJ5-mutated aldosterone-producing adenoma","volume":"103","author":"Inoue","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2021122205025956500_B46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2265.1991.tb00306.x","article-title":"Histological and biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin","volume":"34","author":"Tunny","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2021122205025956500_B47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/EJE-12-0594","article-title":"Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing\u2019s syndrome","volume":"168","author":"Hofland","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2021122205025956500_B48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1507\/endocrj.50.155","article-title":"Cushing\u2019s syndrome due to bilateral adrenocortical adenomas with unique histological features","volume":"50","author":"Nomura","year":"2003","journal-title":"Endocr J"},{"issue":"3","key":"2021122205025956500_B49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ando.2018.03.014","article-title":"Adrenocortical development: Lessons from mouse models","volume":"79","author":"Dumontet","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"2021122205025956500_B50","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.cell.2011.07.046","article-title":"Crystal structure of the mammalian GIRK2 K+ channel and gating regulation by G proteins, PIP2, and sodium","volume":"147","author":"Whorton","year":"2011","journal-title":"Cell"},{"issue":"3","key":"2021122205025956500_B51","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/157340309788970397","article-title":"Iatrogenic QT abnormalities and fatal arrhythmias: mechanisms and clinical significance","volume":"5","author":"Cubeddu","year":"2009","journal-title":"Curr Cardiol Rev"},{"issue":"9","key":"2021122205025956500_B52","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1248\/bpb.b12-00002","article-title":"Blockade of K+ and Ca2+ channels by azole antifungal agents in neonatal rat ventricular myocytes","volume":"35","author":"Sung","year":"2012","journal-title":"Biol Pharm Bull"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab118\/37072477\/dgab118.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/6\/1606\/41850711\/dgab118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/6\/1606\/41850711\/dgab118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T05:07:40Z","timestamp":1640149660000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/6\/1606\/6149606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":52,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,2,25]]},"published-print":{"date-parts":[[2021,5,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab118","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,2,25]]}}}